- Home
- Supplements
- Iron
- Lethargy
Overview
Verdict
A randomised trial in non-anaemic women with low ferritin found significantly reduced fatigue on iron versus placebo. Benefit does not extend to people with normal iron stores.
Unexplained deficiency needs investigating
In men and postmenopausal women, iron deficiency is a red flag for gastrointestinal blood loss. Correcting the ferritin without finding the cause is not enough.
How It Works
Pathways involved
Dosing & Protocol
| Scenario | Dose | Form | Timing |
|---|---|---|---|
| Low ferritin, no anaemia | 40-100 mg elemental, alternate days | Ferrous sulfate | Morning with vitamin C |
| Poor tolerance | 20-30 mg elemental, alternate days | Ferrous bisglycinate | With a light meal |
| On a proton pump inhibitor | 40-65 mg elemental, alternate days | Ferrous sulfate plus ascorbic acid | Expect slower repletion |
| After repletion | Stop and retest | - | 3 months after starting |
- 1
Measure ferritin with CRP· Before starting
Inflammation inflates ferritin. Interpreting one without the other misses deficiency.
- 2
Dose on alternate days with vitamin C· Weeks 1-12
One tablet with a citrus source; skip the intervening day entirely.
- 3
Track effort tolerance, not just mood· Ongoing
Stair climbing, exercise recovery and afternoon slump are more reliable markers than a general sense of energy.
- 4
Retest ferritin at three months· Month 3
Stop when replete. If ferritin has not moved, absorption or ongoing loss needs review.
Do not supplement blind
Fatigue has many causes and iron overload is genuinely harmful. A ferritin result is the difference between a targeted intervention and an unnecessary risk.
Evidence
Linked evidence for this pairing.
Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial
Vaucher P, Druais PL, Waldvogel S +1 more
Iron reduced fatigue by about 48% from baseline versus 29% with placebo in non-anaemic women with low ferritin.
- Best available evidence
- Randomised placebo-controlled trial in non-anaemic women with low ferritin
- Typical effect
- Significant reduction in fatigue score versus placebo
- Studied dose
- Approximately 80 mg elemental iron daily in the trial setting
- Time to effect
- 4-12 weeks
- Certainty of evidence
- Moderate, restricted to low-ferritin populations
Safety
Reported effects
Interactions & Conflicts
| Interacts with | Severity | Mechanism | Action |
|---|---|---|---|
| — | — | ||
| — | — | ||
| — | — | ||
| — | — | ||
| — | — |
References
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.